Alder BioPharmaceuticals (NASDAQ: ALDR) announced that it has regained the worldwide rights to clazakizumab, a humanized monoclonal antibody to the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE